MarketCap
Facebook
X
TelegramQuarterly report 2024-Q1
added 05-14-2024
Motus GI Holdings Operating Expenses 2011-2025 | MOTS
Annual Operating Expenses Motus GI Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 18.6 M | 23.4 M | 18.9 M | 13 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23.4 M | 13 M | 18.5 M |
Quarterly Operating Expenses Motus GI Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | -5 K | - | 4.49 M | - | 3.82 M | 4.21 M | 6.74 M | - | 5.36 M | 5.65 M | 6.36 M | - | 5.13 M | 4.11 M | 4.08 M | - | 3.99 M | 2.51 M | 2.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.74 M | -5 K | 4.23 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 18.7 | -3.44 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 20.72 | -3.9 % | $ 223 M |  China |
 |
Co-Diagnostics
CODX
|
45.3 M | $ 0.23 | -4.09 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 39.24 | -0.39 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 230.65 | 0.13 % | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 10.65 | 6.03 % | $ 302 M | Israel |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.5 | -1.32 % | $ 1.91 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.58 | 0.01 % | $ 18.8 B | USA |
 |
DexCom
DXCM
|
1.69 B | $ 67.74 | 0.25 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 26.54 | -0.67 % | $ 802 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
484 M | $ 19.01 | -2.41 % | $ 1.02 B | USA |
 |
Celcuity
CELC
|
113 M | $ 101.78 | -0.46 % | $ 4.02 B | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 3.2 | - | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 226.28 | -0.28 % | $ 41 B | USA |
 |
Guardant Health
GH
|
226 M | $ 101.9 | -1.05 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
709 M | $ 6.35 | -2.08 % | $ 575 M | USA |
 |
ENDRA Life Sciences
NDRA
|
10.8 M | $ 4.96 | -2.36 % | $ 2.66 M | USA |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 7.16 | 0.35 % | $ 1.55 B | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 18.73 | 0.38 % | $ 460 M | USA |
 |
Illumina
ILMN
|
3.69 B | $ 134.09 | -0.64 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 202.78 | -0.38 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 174.97 | -0.56 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
106 M | $ 6.6 | -3.19 % | $ 856 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 252.66 | -0.51 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 181.48 | -0.74 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.25 B | $ 682.84 | -0.82 % | $ 56.3 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 66.94 | 0.34 % | $ 4.63 B | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 412.33 | -0.55 % | $ 30 B |  Schweiz |
 |
Agilent Technologies
A
|
1.99 B | $ 137.93 | -0.33 % | $ 41.9 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.2 | 0.31 % | $ 20 B |  Niderland |
 |
Biomerica
BMRA
|
5.64 M | $ 2.7 | - | $ 6.2 M | USA |
 |
Bioventus
BVS
|
217 M | $ 7.49 | 0.4 % | $ 469 M | USA |
 |
Personalis
PSNL
|
44.5 M | $ 8.13 | -0.12 % | $ 482 M | USA |